Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like Why Are the Individual Tax Cuts Expiring? Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro Saudi Arabia says all NEOM megaprojects will go ahead as planned despite reports of scaling back Chinese EV start-ups Nio and Xpeng turn to the mass market for growth Demand for riskier adjustable-rate mortgages hits highest level of the year, due to rising rates